
???Effect of neoadjuvant chemotherapy on the immune microenvironment in gastric cancer as determined by multiplex immunofluorescence and T cell receptor repertoire analysis
?????????T??????????NAC???????????????
?????Journal for ImmunoTherapy of Cancer
?????2022?3?
?????12.469
??1416??????-????????????????????????????????1075?????????????1??341???NAC????????2??NAC????????????????????/S-1+?????XELOX?SOX????????????3??30???NAC???II/ III??????????NAC???????????????????????TCR?????
?2) ??????
?3) TCR ??????:?TCR???CDR3?????????
?4) ????


?NAC??????NAC????TCR???????????TCR??????A.B??NAC?TCR?????????????T??????????C)?

??NAC??TCR???????????T????????NAC????T????????????????????D?E??

NAC??D50??????NAC???????Shannon????????NAC???F?G??

?NAC??XELOX????????Shannon???????SOX??TCR??????????????

???Diversity index of mucosal resident T lymphocyte repertoire predicts clinical prognosis in gastric cancer
??T???????????????????
?????Oncoimmunology
?????2015?4?
?????8.11

?????CDR3 AA???????A????????B?????????????????????CDR3????????????????????????PBMC???CDR3???????CDR3 AA????????C???????D?????????

???????V?J???????????????PBMC?????PBMC??????????TIL????t?????????????E)?

??28????????TIL????T?????T?????????????????????????NSDE????????????28?????????????TIL????T???NSDE???????18?????????????48???????????A?B????????TCR??????????????????????????????????????????????C??

???Heterogeneity and evolution of tumour immune microenvironment in metastatic gastroesophageal adenocarcinoma
???????????????????????
?????Gastric Cancer
?????2022?7?
?????7.701
?2????????
?3????seeding??
?4?T??????
?5????????

?TCR?????????????TCR??????????????????????TCR?????????10%?TCR?????????113??????????????????????A??


????????????????????????TCR?????B??????????C?????Shannon???D????????????????????????>?TCR???0.1%????????E??

?????????????????????????TCR???????F???????????????TOP100 TCR??????????????56.5%??????????????????????G??

???Expansion of CD3+CD8+PD1+ T lymphocytes andTCR repertoire diversity predict clinical responses to adoptive cell therapy in advanced gastric cancer
CD3+CD8+PD1+ T????????TCR??????????????????ACT????????
?????American Journal of Cancer Research
?????2022?12?
?????5.942
?2???DC-CIK??
?3???CD8+PD-1+ T??
?4???????????
?5????????????
?6?TCR???????15??TCR V?CDR3?????????TCR????????
?7?????????????

?????15??Shannon????0???????15?????????????????????A??????????15????????TCR????15????????0???A????ROC???????????????/??????<0.7?????0.7??OS?PFS??????/????>1.7???OS?PFS??????/????>0.5?????0.5???OS?PFS??????(?B)

???15?????????????????C????????????TCR????????

????????????????ROC???????????????PFS?OS??D???????????????????

???A novel signature for stratifying the molecular heterogeneity of the tissue-infltrating T-cell receptor repertoire refects gastric cancer prognosis
?????TCR???????????????????
?????Scientific Reports
?????2017?8?
?????4.996
?2??TCR? CDR3?????????
?3????????
?4???TVI?????????

?????LGIN?HGIN?EGC???TOP100??????????????????TOP100??????????50%??????TCR??????????????

TOP100??????????????????????????????????????TCR??????????????

LGIN??????t?????????HGIN??????EGC???????????a??LGIN??????HGIN??????EGC??????????????????????b????????????????????????TCR??????????

?????LGIN?HGIN?EGC???TOP100????????L-100?H-100?E-100?????????TCR????A-TCR????????L-100?A-TCR?????????H-100?A-TCR?E-100?A-TCR????????a)??????????????????????????????b?
ImmuHub®??????????????????NGS?????5’RACE???PCR?????????????RNA?DNA???TCR/BCR??????CDR3??????????????????????????????????TCR/BCR???????
ImmuHub®?????????????????????TCR/BCR??T/B?????????????????????????T???B?????????????????????????????????????????????????????????????????????????????????????????????????

???ImmuHub®???

??????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
